Research Papers

25 of 3340 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with…
Kalsoom S; Rasool MF; Imran I; Saeed H; Ahmad T; Alqahtani F.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pharmacological Topical Therapy for Intra-Oral Post Traumatic Trigeminal Neuropathic Pain: A Comprehensive Review.
Sharav Y; Heiliczer S; Benoliel R; Haviv Y.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Synthesis and Study of the Structure-Activity Relationship of Antiproliferative <i>N</i>-Substituted Isosteviol-Based 1…
Ozsvár D; Bózsity N; Zupkó I; Szakonyi Z.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADM…
Abchir O; Khedraoui M; Nour H; Yamari I; Errougui A; Samadi A; Chtita S.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis.
Minayoshi Y; Maeda H; Hamasaki K; Nagasaki T; Takano M; Fukuda R; Mizuta Y; Tanaka M; Sasaki Y; Otagiri M; Watanabe H; Maruyama T.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Anti-Bacterial Activity of Green Synthesised Silver and Zinc Oxide Nanoparticles against <i>Propionibacterium acnes</i>.
Al-Momani H; Massadeh MI; Almasri M; Al Balawi D; Aolymat I; Hamed S; Albiss BA; Ibrahim L; Balawi HA; Al Haj Mahmoud S.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radiol…
de Roode KE; Joosten L; Behe M.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study.
Laouameria AN; Hunyadi M; Csík A; Szűcs Z.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Advancements in Microfluidic Cassette-Based iMiDEV™ Technology for Production of L-[<sup>11</sup>C]Methionine and [<sup…
Mallapura H; Tanguy L; Mahfuz S; Bylund L; Långström B; Halldin C; Nag S.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administrati…
Di Trana A; Di Giorgi A; Sprega G; Carlier J; Kobidze G; Montanari E; Taoussi O; Bambagiotti G; Fede MS; Lo Faro AF; Tini A; Busardò FP; Pichini S.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Manageme…
Singh S; Tiwary N; Sharma N; Behl T; Antil A; Anwer MK; Ramniwas S; Sachdeva M; Elossaily GM; Gulati M; Ohja S.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Strategies to Improve Cannabidiol Bioavailability and Drug Delivery.
O'Sullivan SE; Jensen SS; Kolli AR; Nikolajsen GN; Bruun HZ; Hoeng J.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Al Shaer D; Al Musaimi O; Albericio F; de la Torre BG.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Advances in the Application of Black Phosphorus-Based Composite Biomedical Materials in the Field of Tissue Engineering.
Qi W; Zhang R; Wang Z; Du H; Zhao Y; Shi B; Wang Y; Wang X; Wang P.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrated UPLC/Q-TOF-MS/MS Analysis and Network Pharmacology to Reveal the Neuroprotective Mechanisms and Potential Ph…
Qiu M; Zhang J; Wei W; Zhang Y; Li M; Bai Y; Wang H; Meng Q; Guo DA.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
An Overview of Biosimilars-Development, Quality, Regulatory Issues, and Management in Healthcare.
Mascarenhas-Melo F; Diaz M; Gonçalves MBS; Vieira P; Bell V; Viana S; Nunes S; Paiva-Santos AC; Veiga F.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pharmacokinetic Analysis of Levodropropizine and Its Potential Therapeutic Advantages Considering Eosinophil Levels and…
Jang JH; Cho YJ; Jeong SH.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Anticancer Evaluation of Novel Benzofuran-Indole Hybrids as Epidermal Growth Factor Receptor Inhibitors against Non-Sma…
Lee Y; Lee S; Lee Y; Song D; Park SH; Kim J; Namkung W; Kim I.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Biological Effects and Biomedical Applications of Areca Nut and Its Extract.
Tong T; Xu A; Tan S; Jiang H; Liu L; Deng S; Wang H.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Hedgehog Pathway Inhibition by Novel Small Molecules Impairs Melanoma Cell Migration and Invasion under Hypoxia.
Falsini A; Giuntini G; Mori M; Ghirga F; Quaglio D; Cucinotta A; Coppola F; Filippi I; Naldini A; Botta B; Carraro F.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer.
Liu Z; Lyu X; Chen J; Zhang B; Xie S; Yuan Y; Sun L; Yuan S; Yu H; Ding J; Yang M.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
How Can Deep Eutectic Systems Promote Greener Processes in Medicinal Chemistry and Drug Discovery?
Domingues L; Duarte ARC; Jesus AR.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Cold-Pressed Sacha Inchi Oil: High in Omega-3 and Prevents Fat Accumulation in the Liver.
Samrit T; Osotprasit S; Chaiwichien A; Suksomboon P; Chansap S; Athipornchai A; Changklungmoa N; Kueakhai P.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients.
Gaita L; Timar B; Timar R; Fras Z; Gaita D; Banach M.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Antenatal Magnesium Sulfate Benefits Female Preterm Infants but Results in Poor Male Outcomes.
McLeod RM; Rosenkrantz TS; Fitch RH.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared